I.J.A.M. Jonkers

721 total citations
18 papers, 541 citations indexed

About

I.J.A.M. Jonkers is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, I.J.A.M. Jonkers has authored 18 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in I.J.A.M. Jonkers's work include Lipid metabolism and disorders (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). I.J.A.M. Jonkers is often cited by papers focused on Lipid metabolism and disorders (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). I.J.A.M. Jonkers collaborates with scholars based in Netherlands, Sweden and United States. I.J.A.M. Jonkers's co-authors include Rudi G. J. Westendorp, A.H.M. Smelt, Arnoud van der Laarse, Martina F Mohrschladt, Annelies W. E. Weverling‐Rijnsburger, Jacobijn Gussekloo, Eric van Exel, Ad Masclee, Renze Boverhof and Marjolijn van Buren and has published in prestigious journals such as Gut, Annals of the New York Academy of Sciences and The American Journal of Medicine.

In The Last Decade

I.J.A.M. Jonkers

17 papers receiving 527 citations

Peers

I.J.A.M. Jonkers

SURGE

EDM

EPIDE

CCM

M. El-Nahas United Kingdom

F. Heller Belgium

Shinichi Mashiba Japan

Yonghee Lee South Korea

H Vaverková Czechia

Horațiu Silaghi Romania

Bijan Roshan United States

Alexandros Sachinidis Greece

C B Marenah United Kingdom

Mary Mamakeesick Canada

M. El-Nahas United Kingdom

I.J.A.M. Jonkers

249 ×1.1

SURGE

244 ×1.2

EDM

111 ×0.8

EPIDE

112 ×1.0

CCM

164 ×1.6

Citations per year, relative to I.J.A.M. Jonkers I.J.A.M. Jonkers (= 1×) peers M. El-Nahas

Countries citing papers authored by I.J.A.M. Jonkers

Since Specialization

Citations

This map shows the geographic impact of I.J.A.M. Jonkers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.J.A.M. Jonkers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.J.A.M. Jonkers more than expected).

Fields of papers citing papers by I.J.A.M. Jonkers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.J.A.M. Jonkers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.J.A.M. Jonkers. The network helps show where I.J.A.M. Jonkers may publish in the future.

Co-authorship network of co-authors of I.J.A.M. Jonkers

This figure shows the co-authorship network connecting the top 25 collaborators of I.J.A.M. Jonkers. A scholar is included among the top collaborators of I.J.A.M. Jonkers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.J.A.M. Jonkers. I.J.A.M. Jonkers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Jonkers, I.J.A.M. & Marjolijn van Buren. (2009). Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma. Clinical and Experimental Nephrology. 13(4). 397–401. 13 indexed citations

Gelinck, L. B. S., et al.. (2008). Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism. Journal of Infection. 57(6). 485–488. 4 indexed citations

Jonkers, I.J.A.M., A.H.M. Smelt, P. Hans, et al.. (2006). Fish Oil Increases Bile Acid Synthesis in Male Patients with Hypertriglyceridemia. Journal of Nutrition. 136(4). 987–991. 25 indexed citations

Verkuijlen, Paul J.J.H., et al.. (2004). Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals. European Journal of Human Genetics. 12(11). 935–941. 20 indexed citations

Jonkers, I.J.A.M., Jan A. Bruijn, & Louis‐Jean Vleming. (2004). A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria. American Journal of Kidney Diseases. 44(4). 773–777.

Weverling‐Rijnsburger, Annelies W. E., I.J.A.M. Jonkers, Eric van Exel, Jacobijn Gussekloo, & Rudi G. J. Westendorp. (2003). High-Density vs Low-Density Lipoprotein Cholesterol as the Risk Factor for Coronary Artery Disease and Stroke in Old Age. Archives of Internal Medicine. 163(13). 1549–1549. 145 indexed citations

Jonkers, I.J.A.M., A.H.M. Smelt, Hiroaki Hattori, et al.. (2003). Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG. Journal of Lipid Research. 44(8). 1462–1469. 32 indexed citations

Jonkers, I.J.A.M., A.H.M. Smelt, M. Ledeboer, et al.. (2002). Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 52(1). 109–115. 46 indexed citations

Jonkers, I.J.A.M.. (2002). Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia. Cardiovascular Research. 53(2). 496–501. 19 indexed citations

10.

Jonkers, I.J.A.M., Martina F Mohrschladt, Rudi G. J. Westendorp, Arnoud van der Laarse, & A.H.M. Smelt. (2002). Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. The American Journal of Medicine. 112(4). 275–280. 137 indexed citations

11.

Jonkers, I.J.A.M., Nico H. van Tilburg, A. van der Laarse, et al.. (2001). Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a ‘procoagulant state': effects of bezafibrate therapy. Blood Coagulation & Fibrinolysis. 12(8). 705–712. 3 indexed citations

12.

Jonkers, I.J.A.M., Arnoud van der Laarse, Marijke Frölich, et al.. (2001). Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. Journal of Hypertension. 19(4). 749–755. 35 indexed citations

13.

Jonkers, I.J.A.M., et al.. (2001). Hypertriglyceridemia. American Journal of Cardiovascular Drugs. 1(6). 455–466. 15 indexed citations

14.

Jonkers, I.J.A.M., M. Ledeboer, Jeroen Steens, A.H.M. Smelt, & Ad Masclee. (2000). Effects of Very Long Chain Versus Long Chain Triglycerides on Gastrointestinal Motility and Hormone Release in Humans. Digestive Diseases and Sciences. 45(9). 1719–1726. 12 indexed citations

15.

Man, Frits H.A.F. de, I.J.A.M. Jonkers, Edzard Schwedhelm, et al.. (2000). Normal Oxidative Stress and Enhanced Lipoprotein Resistance to In Vitro Oxidation in Hypertriglyceridemia. Arteriosclerosis Thrombosis and Vascular Biology. 20(11). 2434–2440. 13 indexed citations

16.

Jonkers, I.J.A.M., et al.. (2000). Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. Atherosclerosis. 151(1). 226–226. 2 indexed citations

17.

Matell, Georg, et al.. (1998). Calcium Channel and β‐Receptor Antagonists and Agonists in MG^a. Annals of the New York Academy of Sciences. 841(1). 785–788. 5 indexed citations

18.

Jonkers, I.J.A.M., et al.. (1996). Acute effects of intravenous injection of beta-adrenoreceptor- and calcium-channel antagonists and agonists in myasthenia gravis. Muscle & Nerve. 19(8). 959–965. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact